Human goodpasture anti-α3(IV)NC1 autoantibodies share structural determinants: Rapid communication

Kevin E.C. Meyers, Paul A. Kinniry, Raghuram Kalluri, Eric G. Neilson, Michael P. Madaio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To examine the structural relationship among autoantibodies produced by individuals with anti-GBM antibody-mediated disease, a polyclonal anti- idiotype directed against human anti-α3(IV)NC1 antibodies was produced and then used to study autoantibodies from other patients. For this purpose, anti-α3(IV)NC1 antibodies (anti-GBM), derived from a single patient (LL) with high titer and typical anti-GBM antibody specificity, were isolated using recombinant α3(IV)NC1-sepharose affinity chromatography. Following hyperimmunization of rabbits with anti-GBM IgG, irrelevant rabbit anti-human IgG antibodies were removed from the antiserum using a human IgG-sepharose column. The rabbit anti-α3(IV)NC1 antibodies (anti-Id GBM) effluent bound to human anti-GBM antibodies, but it did not bind to either normal human IgG or recombinant α3(IV)NC1 protein. The Id-anti-Id interaction was conformationally dependent on intact heavy and light chains of the anti- α3(IV)NC1 antibodies (ELISA and Western blotting). A competitive immunoassay was developed to evaluate structural and potential genetic relationships among anti-α3(IV)NC1 antibodies from different patients. All patients tested (9 of 9) had a substantial fraction (producing > 50% inhibition) of anti-GBM antibodies expressing Id-GBM. The results indicate that shared determinants are expressed by anti-GBM antibodies from different individuals, and they raise the possibility that common genetic elements are used to encode them. These regions are potential targets for design of reagents to regulate autoreactive B cells and/or interfere with pathogenic antibody-GBM interactions, in individuals with anti-GBM antibody mediated diseases.

Original languageEnglish (US)
Pages (from-to)402-407
Number of pages6
JournalKidney International
Volume53
Issue number2
DOIs
StatePublished - Jan 1 1998

Fingerprint

Autoantibodies
Communication
Anti-Idiotypic Antibodies
Antibodies
Rabbits
antiglomerular basement membrane antibody
Agarose Chromatography
Antibody Specificity
Affinity Chromatography
Immunoassay
Immune Sera
B-Lymphocytes
Immunoglobulin G
Western Blotting
Enzyme-Linked Immunosorbent Assay
Light

Keywords

  • Antiglomerular basement membrane disease
  • Conformational anti-idiotype
  • Goodpasture disease
  • Shared epitopes

ASJC Scopus subject areas

  • Nephrology

Cite this

Human goodpasture anti-α3(IV)NC1 autoantibodies share structural determinants : Rapid communication. / Meyers, Kevin E.C.; Kinniry, Paul A.; Kalluri, Raghuram; Neilson, Eric G.; Madaio, Michael P.

In: Kidney International, Vol. 53, No. 2, 01.01.1998, p. 402-407.

Research output: Contribution to journalArticle

Meyers, Kevin E.C. ; Kinniry, Paul A. ; Kalluri, Raghuram ; Neilson, Eric G. ; Madaio, Michael P. / Human goodpasture anti-α3(IV)NC1 autoantibodies share structural determinants : Rapid communication. In: Kidney International. 1998 ; Vol. 53, No. 2. pp. 402-407.
@article{84d04c523e874cfe80190bec561cc212,
title = "Human goodpasture anti-α3(IV)NC1 autoantibodies share structural determinants: Rapid communication",
abstract = "To examine the structural relationship among autoantibodies produced by individuals with anti-GBM antibody-mediated disease, a polyclonal anti- idiotype directed against human anti-α3(IV)NC1 antibodies was produced and then used to study autoantibodies from other patients. For this purpose, anti-α3(IV)NC1 antibodies (anti-GBM), derived from a single patient (LL) with high titer and typical anti-GBM antibody specificity, were isolated using recombinant α3(IV)NC1-sepharose affinity chromatography. Following hyperimmunization of rabbits with anti-GBM IgG, irrelevant rabbit anti-human IgG antibodies were removed from the antiserum using a human IgG-sepharose column. The rabbit anti-α3(IV)NC1 antibodies (anti-Id GBM) effluent bound to human anti-GBM antibodies, but it did not bind to either normal human IgG or recombinant α3(IV)NC1 protein. The Id-anti-Id interaction was conformationally dependent on intact heavy and light chains of the anti- α3(IV)NC1 antibodies (ELISA and Western blotting). A competitive immunoassay was developed to evaluate structural and potential genetic relationships among anti-α3(IV)NC1 antibodies from different patients. All patients tested (9 of 9) had a substantial fraction (producing > 50{\%} inhibition) of anti-GBM antibodies expressing Id-GBM. The results indicate that shared determinants are expressed by anti-GBM antibodies from different individuals, and they raise the possibility that common genetic elements are used to encode them. These regions are potential targets for design of reagents to regulate autoreactive B cells and/or interfere with pathogenic antibody-GBM interactions, in individuals with anti-GBM antibody mediated diseases.",
keywords = "Antiglomerular basement membrane disease, Conformational anti-idiotype, Goodpasture disease, Shared epitopes",
author = "Meyers, {Kevin E.C.} and Kinniry, {Paul A.} and Raghuram Kalluri and Neilson, {Eric G.} and Madaio, {Michael P.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1046/j.1523-1755.1998.00827.x",
language = "English (US)",
volume = "53",
pages = "402--407",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Human goodpasture anti-α3(IV)NC1 autoantibodies share structural determinants

T2 - Rapid communication

AU - Meyers, Kevin E.C.

AU - Kinniry, Paul A.

AU - Kalluri, Raghuram

AU - Neilson, Eric G.

AU - Madaio, Michael P.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - To examine the structural relationship among autoantibodies produced by individuals with anti-GBM antibody-mediated disease, a polyclonal anti- idiotype directed against human anti-α3(IV)NC1 antibodies was produced and then used to study autoantibodies from other patients. For this purpose, anti-α3(IV)NC1 antibodies (anti-GBM), derived from a single patient (LL) with high titer and typical anti-GBM antibody specificity, were isolated using recombinant α3(IV)NC1-sepharose affinity chromatography. Following hyperimmunization of rabbits with anti-GBM IgG, irrelevant rabbit anti-human IgG antibodies were removed from the antiserum using a human IgG-sepharose column. The rabbit anti-α3(IV)NC1 antibodies (anti-Id GBM) effluent bound to human anti-GBM antibodies, but it did not bind to either normal human IgG or recombinant α3(IV)NC1 protein. The Id-anti-Id interaction was conformationally dependent on intact heavy and light chains of the anti- α3(IV)NC1 antibodies (ELISA and Western blotting). A competitive immunoassay was developed to evaluate structural and potential genetic relationships among anti-α3(IV)NC1 antibodies from different patients. All patients tested (9 of 9) had a substantial fraction (producing > 50% inhibition) of anti-GBM antibodies expressing Id-GBM. The results indicate that shared determinants are expressed by anti-GBM antibodies from different individuals, and they raise the possibility that common genetic elements are used to encode them. These regions are potential targets for design of reagents to regulate autoreactive B cells and/or interfere with pathogenic antibody-GBM interactions, in individuals with anti-GBM antibody mediated diseases.

AB - To examine the structural relationship among autoantibodies produced by individuals with anti-GBM antibody-mediated disease, a polyclonal anti- idiotype directed against human anti-α3(IV)NC1 antibodies was produced and then used to study autoantibodies from other patients. For this purpose, anti-α3(IV)NC1 antibodies (anti-GBM), derived from a single patient (LL) with high titer and typical anti-GBM antibody specificity, were isolated using recombinant α3(IV)NC1-sepharose affinity chromatography. Following hyperimmunization of rabbits with anti-GBM IgG, irrelevant rabbit anti-human IgG antibodies were removed from the antiserum using a human IgG-sepharose column. The rabbit anti-α3(IV)NC1 antibodies (anti-Id GBM) effluent bound to human anti-GBM antibodies, but it did not bind to either normal human IgG or recombinant α3(IV)NC1 protein. The Id-anti-Id interaction was conformationally dependent on intact heavy and light chains of the anti- α3(IV)NC1 antibodies (ELISA and Western blotting). A competitive immunoassay was developed to evaluate structural and potential genetic relationships among anti-α3(IV)NC1 antibodies from different patients. All patients tested (9 of 9) had a substantial fraction (producing > 50% inhibition) of anti-GBM antibodies expressing Id-GBM. The results indicate that shared determinants are expressed by anti-GBM antibodies from different individuals, and they raise the possibility that common genetic elements are used to encode them. These regions are potential targets for design of reagents to regulate autoreactive B cells and/or interfere with pathogenic antibody-GBM interactions, in individuals with anti-GBM antibody mediated diseases.

KW - Antiglomerular basement membrane disease

KW - Conformational anti-idiotype

KW - Goodpasture disease

KW - Shared epitopes

UR - http://www.scopus.com/inward/record.url?scp=0031951559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031951559&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.1998.00827.x

DO - 10.1046/j.1523-1755.1998.00827.x

M3 - Article

C2 - 9461099

AN - SCOPUS:0031951559

VL - 53

SP - 402

EP - 407

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -